Cargando…

Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging

OBJECTIVE: Parkinson disease is characterized by motor and nonmotor symptoms, reduced striatal dopamine signaling, and loss of dopamine neurons in the substantia nigra. It is now known that the pathological process in Parkinson disease may begin decades before the clinical diagnosis and include a va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matuskey, David, Tinaz, Sule, Wilcox, Kyle C., Naganawa, Mika, Toyonaga, Takuya, Dias, Mark, Henry, Shannan, Pittman, Brian, Ropchan, Jim, Nabulsi, Nabeel, Suridjan, Ivonne, Comley, Robert A., Huang, Yiyun, Finnema, Sjoerd J., Carson, Richard E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065227/ https://www.ncbi.nlm.nih.gov/pubmed/31953875 http://dx.doi.org/10.1002/ana.25682

Ejemplares similares

Feasibility of imaging synaptic density in the human spinal cord using [(11)C]UCB-J PET
por: Rossano, Samantha, et al.
Publicado: (2022)

Human adult and adolescent biodistribution and dosimetry of the synaptic vesicle glycoprotein 2A radioligand (11)C-UCB-J
por: Bini, Jason, et al.
Publicado: (2020)

Imaging the effect of ketamine on synaptic density (SV2A) in the living brain
por: Holmes, Sophie E, et al.
Publicado: (2022)

Lower synaptic density is associated with depression severity and network alterations
por: Holmes, Sophie E., et al.
Publicado: (2019)

A single‐center, open‐label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers
por: Finnema, Sjoerd J., et al.
Publicado: (2019)

Preliminary In Vivo Evidence of Reduced Synaptic Density in Human Immunodeficiency Virus (HIV) Despite Antiretroviral Therapy
por: Weiss, Julian J, et al.
Publicado: (2021)

2181 Age-related change in 5-HT6 receptor availability in healthy male volunteers measured with 11C-GSK215083 PET
por: Radhakrishnan, Rajiv, et al.
Publicado: (2018)

A metabolically stable PET tracer for imaging synaptic vesicle protein 2A: synthesis and preclinical characterization of [(18)F]SDM-16
por: Zheng, Chao, et al.
Publicado: (2021)

Drug characteristics derived from kinetic modeling: combined (11)C-UCB-J human PET imaging with levetiracetam and brivaracetam occupancy of SV2A
por: Naganawa, Mika, et al.
Publicado: (2022)

Association of Aβ deposition and regional synaptic density in early Alzheimer’s disease: a PET imaging study with [(11)C]UCB-J
por: O’Dell, Ryan S., et al.
Publicado: (2021)

Nicotine Patch Alters Patterns of Cigarette Smoking-Induced Dopamine Release: Patterns Relate to Biomarkers Associated With Treatment Response
por: Zakiniaeiz, Yasmin, et al.
Publicado: (2022)

Neurotransmitter transporter occupancy following administration of centanafadine sustained-release tablets: A phase 1 study in healthy male adults
por: Matuskey, David, et al.
Publicado: (2022)

Principal component analysis of synaptic density measured with [(11)C]UCB-J PET in early Alzheimer’s disease
por: O'Dell, Ryan S., et al.
Publicado: (2023)

In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET
por: Mecca, Adam P., et al.
Publicado: (2020)

Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [(11)C]UCB‐J
por: Mecca, Adam P., et al.
Publicado: (2022)

RF12 | PSUN106 Quantifying Liver and Brain Levels of 11β-hydroxysteroid Dehydrogenase Type 1 in Obesity Using Positron Emission Tomography Imaging
por: Bini, Jason, et al.
Publicado: (2022)

Further Investigation of Synaptic Vesicle Protein 2A (SV2A) Ligands Designed for Positron Emission Tomography and Single-Photon Emission Computed Tomography Imaging: Synthesis and Structure–Activity Relationship of Substituted Pyridinylmethyl-4-(3,5-difluorophenyl)pyrrolidin-2-ones
por: Pracitto, Richard, et al.
Publicado: (2021)

The Search for a Subtype-Selective PET Imaging Agent for the GABA(A) Receptor Complex: Evaluation of the Radiotracer [(11)C]ADO in Nonhuman Primates
por: Lin, Shu-fei, et al.
Publicado: (2017)

Quantification of myocardial blood flow with (82)Rb: Validation with (15)O-water using time-of-flight and point-spread-function modeling
por: Germino, Mary, et al.
Publicado: (2016)

Systemic inflammation enhances stimulant-induced striatal dopamine elevation in tobacco smokers
por: Zakiniaeiz, Yasmin, et al.
Publicado: (2022)

PET Imaging of Synaptic Density: Challenges and Opportunities of Synaptic Vesicle Glycoprotein 2A PET in Small Animal Imaging
por: Toyonaga, Takuya, et al.
Publicado: (2022)

Identifying brain networks in synaptic density PET ((11)C-UCB-J) with independent component analysis
por: Fang, Xiaotian T., et al.
Publicado: (2021)

Magnetic resonance imaging modalities aid in the differential diagnosis of atypical parkinsonian syndromes
por: Tinaz, Sule
Publicado: (2023)

Decreased synaptic vesicle glycoprotein 2A binding in a rodent model of familial Alzheimer's disease detected by [(18)F]SDM-16
por: Zheng, Chao, et al.
Publicado: (2023)

Partial volume correction analysis for (11)C-UCB-J PET studies of Alzheimer’s disease
por: Lu, Yihuan, et al.
Publicado: (2021)

Adaptive data-driven motion detection and optimized correction for brain PET
por: Revilla, Enette Mae, et al.
Publicado: (2022)

In Vivo Imaging and Kinetic Modeling of Novel Glycogen Synthase Kinase-3 Radiotracers [(11)C]OCM-44 and [(18)F]OCM-50 in Non-Human Primates
por: Smart, Kelly, et al.
Publicado: (2023)

Sequence Effect in Parkinson’s Disease Is Related to Motor Energetic Cost
por: Tinaz, Sule, et al.
Publicado: (2016)

Repetitive Transcranial Magnetic Stimulation in Cervical Dystonia: Effect of Site and Repetition in a Randomized Pilot Trial
por: Pirio Richardson, Sarah, et al.
Publicado: (2015)

Characterization of Early Stage Parkinson's Disease From Resting-State fMRI Data Using a Long Short-Term Memory Network
por: Guo, Xueqi, et al.
Publicado: (2022)

Elevated Brain Cannabinoid CB(1) Receptor Availability in Posttraumatic Stress Disorder: A Positron Emission Tomography Study
por: Neumeister, Alexander, et al.
Publicado: (2013)

PTSD is associated with neuroimmune suppression: evidence from PET imaging and postmortem transcriptomic studies
por: Bhatt, Shivani, et al.
Publicado: (2020)

Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [(11)C]ABP688 and PET imaging study in depression
por: Esterlis, Irina, et al.
Publicado: (2017)

Decreased Synaptic Vesicle Glycoprotein 2A Binding in the Human Postmortem Essential Tremor Cerebellum: Evidence of Reduction in Synaptic Density
por: Yang, Yanghong, et al.
Publicado: (2023)

Current Diagnostic Pathways for Alzheimer’s Disease: A Cross-Sectional Real-World Study Across Six Countries
por: Roth, Sophie, et al.
Publicado: (2023)

PET imaging reveals lower kappa opioid receptor availability in alcoholics but no effect of age
por: Vijay, Aishwarya, et al.
Publicado: (2018)

Changes in functional organization and white matter integrity in the connectome in Parkinson's disease
por: Tinaz, Sule, et al.
Publicado: (2016)

PET Imaging in Animal Models of Alzheimer’s Disease
por: Chen, Baosheng, et al.
Publicado: (2022)

Goal-directed behavior in individuals with mild Parkinson's disease: Role of self-efficacy and self-regulation
por: Tinaz, Sule, et al.
Publicado: (2020)

Microglial depletion and activation: A [(11)C]PBR28 PET study in nonhuman primates
por: Hillmer, Ansel T., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cr9ve9ambf1llpu5bncufhh08k